COMPANY PROFILE

ArkeaBio

Explore full profile

A pioneer in developing technology to reduce greenhouse gas (GHG) emissions from the agricultural sector

Boston, United StatesFounded 2021Food

Valuation $50–100M Last recorded · 2026

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About ArkeaBio

ArkeaBio is a pioneering agricultural biotechnology company focused on developing innovative vaccines to reduce methane emissions from cows and enhance ruminal health. Operating within the clean technology sector, ArkeaBio serves the agricultural industry, particularly livestock farmers and dairy producers. The company leverages advanced biotechnological research to adapt its vaccine targets, ensuring they remain effective against the evolving ruminal microbiome influenced by regional, feed, and seasonal variations. ArkeaBio's business model revolves around the development and commercialization of these vaccines, generating revenue through product sales and potentially through government grants and subsidies aimed at reducing environmental impact. The company has received significant funding from the Government of Alberta, highlighting its role in the Emissions Reduction Alberta Emerging Innovators Challenge. By continuously validating the benefits of its products through extensive data collection and analysis, ArkeaBio aims to provide measurable improvements in animal health and environmental sustainability.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2021
Headquarters: Boston, United States
Employees: 36
Open positions: None listed
Dealroom signal: 72.1/100
Industry: Food
Sub-industry: AgriTech
Sector: Food, Sustainable Development Goals, Climate Tech, Methane, Hard Tech
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
EARLY VC✓Equity / VC	Oct 2025	$0	—	Undisclosed	↗
SERIES A✓Equity / VC	Sep 2025	$7M	$133M	Breakthrough Energy Ventures · AgriZeroNZ	↗

Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

ArkeaBio website traffic

Latest recorded traffic for ArkeaBio is 1.3K monthly website visits, up 18.2% over the last three months. ArkeaBio's team declined 10% over the past year.

Latest monthly visits1.3K 3-month web change+18.2% 1-year team growth-10%

Monthly website visitsFeb 2023–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
LILiORAReal-time subsurface monitoring and predictive analytics to drive faster, data-driven site remediation	Edmonton, Canada	Operational	33	$9.3M	$15M
CGCH4 GlobalDeveloped an initiative to cut methane emissions from livestock using a seaweed bio-product	Henderson, United States	Operational
BBBlue Ocean BarnsOn a mission to solve the global climate impact of cattle by working with farmers and food companies to commercialize and radically scale the production and use of our unique feed ingredient	Redwood City, United States	Operational
ABAlga BiosciencesWe are decreasing agricultural methane emissions	San Francisco, United States	Operational
FUFutureFeedA nnatural ingredient for livestock to significantly reduce carbon emissions	Launceston, Australia	Operational
SYSymbrosiaSeaweed feed additive reducing livestock methane emissions	Kailua (Hawaiʻi County), United States	Operational
PAProvectus AlgaeSustainable biomanufacturing platform	Noosaville, Australia	Operational
DUDualMethaAnaerobic digestion technology capable of processing all inputs thanks to the combination of continuous liquid digestion with discontinuous solid digestion	Paris, France	Operational